Abstract
HIV strand transfer inhibitors (INSTIs) have become increasingly popular options for the initiation of antiretroviral therapy (ART). To analyze the prevalence of transmitted INSTI resistance, researchers conducted the Swiss HIV Cohort Study (SHCS) between 2008 (at INSTI introduction in Switzerland) and 2014, with minor pharmaceutical support. The highly representative cohort for HIV infection in Switzerland includes 85% of newly HIV-infected people and at least 75% of all …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
